Biocon's biosimilar Insulin Glargine to be listed on Express

New Delhi, Oct 21: Biocon Biologics Ltd (BBL) on Thursday said its interchangeable biosimilar Insulin Glargine, under brand name Semglee, would be listed

Related Keywords

New Delhi , Delhi , India , United States , America , Arun Chandavarkar , Biocon Biologics , Biocon Biologics Ltd , Script National Preferred Formulary , Biocon , Drug Administration , Scripts Inc , Insulin Glargine , Express Script National Preferred Formulary , Express Scripts , Director Arun Chandavarkar , North America ,